In cooperation with the College of Psychiatric and Neurologic Pharmacists (CPNP), APNA is pleased to bring you another excellenteducational opportunity. CPNP and APNA are working together to bring APNA membersCPNP’s Psychiatric Pharmacotherapy Review Course, all new in 2012.

APNA members can access this Accreditation Council for Pharmacy Education (ACPE)approved distance education course at CPNPmember prices. Both a for-credit and a no-credit(resource only) purchase option is provided. The 20.0 contact hours of ACPE credit areaccepted for American Nurses CredentialingCenter Certification Renewal. Read on to learn more about this great APNA offer andregister online at cpnp.org/apna or via faxor mail using the attached registration form.

2012-2013 APNA EndorsedCPNP Psychiatric Pharmacotherapy

Review Course

8055

O S

treet

, Ste

. S11

3Li

ncol

n, N

E 68

510

info

@cp

np.o

rgcp

np.o

rg/a

pna

Registration Form

Check Credit Card

Name:

Degrees/Certifications:

____________________________________________

_____________________________

APNA # (If Applicable): _____________________________

NABP/CPE Monitor #: _______________________________

Date of Birth:

Position: __________________________________________

Employer: _________________________________________

Preferred Mailing Address: Work HomeWork Address: ________________________________Work City: ___________________________________Work State/Country/Zip: _______________________Work Phone: ___________ Work Fax: ____________

Preferred Email:

______________________________(CPNP does not sell email addresses)

Please print and fully complete all fields

Home Address: _______________________________Home City: ___________________________________Home State/Country/Zip: _______________________Home Phone: ___________ Home Fax: ____________

PaymentPsychiatric Pharmacotherapy Review Course For Credit at $320 (Member) $ __________

No Credit at $150 (Member or Non Member) $ __________

For Credit at $480 (Non Member)

$ __________ Expedited 2 day Delivery at $15 $ __________ Shipment Outside of US at $40 $ __________

Total $ __________

Account #: Expiration Date: / CVV # Name on Card: ___________________________________

Billing Address: __________________________________

City/State/Zip: ________________________________

Signature: ___________________________________

Fax completed registration form to 888-551-7617 or mail to CPNP, 8055 O St, Ste S113, Lincoln NE 68510

/ /

Reg

iste

r now

for

APN

A En

dors

edPs

ychi

atric

Phar

mac

othe

rapy

Rev

iew

Cou

rse

(mycpemonitor.com)

Course ObjectivesAfter completing this course, the participant will beable to:

1. Describe the etiology, risk factors, pathophysiology, and treatment of the following: schizophrenia and other psychotic disorders, neurological disorders, psychiatric disorders in children and adolescents, anxiety disorders, sleep disorders, substance use disorders, bipolar disorders, developmental disorders, psychiatric disorders in the elderly, eating disorders, personality disorders, seizure disorders, and depression.2. Identify common signs and symptoms based on the DSM IV-TR criteria, the presentation, and clinical course of the above named psychiatric disorders.3. Resolve drug therapy problems by modifying the pharmacotherapeutic plan and developing an appropriate monitoring plan for people with the above named disorders. 4. Outline a plan to prevent or manage adverse reactions and drug-drug interactions for patients receiving pharmacologic treatment for the above named disorders. 5. Provide appropriate patient and family counseling for people with mental illness and assist patients in identifying ogranizations that provide support and advocacy.

6. Evaluate and interpret the biomedical literature to enhance the pharmacotherapy of patients withpsychiatric and neurologic conditions.

7. Describe the roles of regulatory organizations andhow they affect psychiatric and neurologic pharmacypractice and the standards of patient care.

The College of Psychiatric and NeurologicPharmacists is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 CPNP-APNA Psychiatric Pharmacotherapy Review

Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

The cost of this distance education program is $320 at member rates and $480 at non-member rates. The course is alsoavailable as a no-credit option at $150 for members andnon-members. Additional information on this course is

available at cpnp.org/apna

Course Components Include1. A book containing 14 modules each consisting of a comprehensive outline on the topic area, expansive references, and self-assessment questions.2. Online access to expert, case-based speaker presentations on the 14 topics.3. Access to the CPNP testing center with exam submission due by December 31, 2013 (for-credit version only).4. Up to twenty contact hours (20.0) of ACPE credit upon successful completion of the required examinations for each topic area (for-credit version only).

Course RequirementsTo satisfactorily complete the CPNP Review Course in Psychiatric Pharmacy (for-credit version) and receive up to 20.0 contact hours of ACPE credit, registrants must meet the following requirements:

Abide by a confidentiality and honesty statement requiring individual completion of the Review Course.

College of Psychiatric &Neurologic Pharmacists (CPNP)8055 O Street, Ste S113Lincoln, NE 68510(402) 476-1677 phone(888) 551-7617 fax Email: info@cpnp.orgWebsite: cpnp.org

ACurriculum and uthors/Speakers

1.0 Aggression,Agitation andDelirium

Matthew Fuller, PharmD, BCPS,BCPP, FASHPClinical Pharmacy SpecialistLouis Stokes Clevelend VAMC

Sarah Melton, PharmD, BCPP, CGPDirector of ACP Addiction Outreach,Associate Professor of PharmacyPractice, Appalachian College ofPharmacy

Linda Tyler, PharmD, AdministrativeDirector of Pharmacy Services,University of Utah Hospitals and Clinics

Rene Endow-Eyer, PharmD, BCPPPsychiatric Clinical Pharmacy Specialst,VA San Diego Healthcare System

Beth Hall, PharmD, BCPP, ClinicalManager, Fulton State Hospital

Karen Rascati, PhD, Professor,The University of Texas College ofPharmacy

Jason Noel, PharmD, BCPP, AssistantProfessor, University of MarylandSchool of Pharmacy

Kelly Gable, PharmD, BCPPAssistant Professor, Southern IllinoisUniversity School of Pharmacy

Ben Chavez, PharmD, BCPPClinical Assistant Professor, RutgersState University of New Jersey

Christopher Thomas, PharmD,BCPP, BCPS, CGP, FASCP, ClinicalPharmacy Specialist in Psychiatry,Chillicothe Department of VeteransAffairs Medical Center

Ann Richards, PharmD, BCPPPharmacy Director, Texas Departmentof State Health Services

Mary Borovicka, PharmD, BCPP,BCPS, Associate Professor, Universityof Toledo

Michael Wincor, PharmD, BCPPAssociate Professor, University ofSouthern California School ofPharmacy and Medicine

1.5 AnxietyDisorders

1.5 Biostatistics andResearch Designin Psychiatry

1.5 BipolarDisorder

1.5 Depression

1.5 Economic andOutcome Studiesin Psychiatry

1.5 NeurologicDisorders

1.0 Personality andEating Disorders

1.0 PediatricPsychiatric Issues

1.5 PsychiatricIssues inthe Elderly

2.0 Regulatory Issuesin PharmacyPractice

Troy Moore, PharmD, MSPharm,BCPP, Assistant Professor,Schizophrenia and Related Disorders,The University of Texas HealthSciences Center

1.5 Schizophreniaand MovementDisorders

1.5 Sleep Disorders

1.5 SubstanceAbuse Disorders

Hours Topics Curriculum Authors & Speakers

•

•

•

Complete an online examination for each of the 14 topic areas by the deadline of December 31, 2013.Meet the minimum passing score of 60% on each of the 14 examinations. Partial credit is available with up to 20 ACPE contact hours achievable upon successfulcompletion of each examination.

Pharmacotherapy Review Course TestimonialsThe course was great as both a resource and a review! I really appreciate having the option of a quality course asa distance option! —Patti GardnerThis review course is a great refresher of psychopharmacology, especially for those healthcare professionals prescribing or administering psychiatric medications on a routine basis. The self-paced learning format with both audio and visual educational tools makes the process very convenient. I highly recommend this review course for nurses, especially APNs, as a valuable continuing education opportunity.

—Jennifer Boggs, MSN, PMHNP-BC

Course ObjectivesAfter completing this course, the participant will beable to:

1. Describe the etiology, risk factors, pathophysiology, and treatment of the following: schizophrenia and other psychotic disorders, neurological disorders, psychiatric disorders in children and adolescents, anxiety disorders, sleep disorders, substance use disorders, bipolar disorders, developmental disorders, psychiatric disorders in the elderly, eating disorders, personality disorders, seizure disorders, and depression.2. Identify common signs and symptoms based on the DSM IV-TR criteria, the presentation, and clinical course of the above named psychiatric disorders.3. Resolve drug therapy problems by modifying the pharmacotherapeutic plan and developing an appropriate monitoring plan for people with the above named disorders. 4. Outline a plan to prevent or manage adverse reactions and drug-drug interactions for patients receiving pharmacologic treatment for the above named disorders. 5. Provide appropriate patient and family counseling for people with mental illness and assist patients in identifying ogranizations that provide support and advocacy.

6. Evaluate and interpret the biomedical literature to enhance the pharmacotherapy of patients withpsychiatric and neurologic conditions.

7. Describe the roles of regulatory organizations andhow they affect psychiatric and neurologic pharmacypractice and the standards of patient care.

The College of Psychiatric and NeurologicPharmacists is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 CPNP-APNA Psychiatric Pharmacotherapy Review

Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

The cost of this distance education program is $320 at member rates and $480 at non-member rates. The course is alsoavailable as a no-credit option at $150 for members andnon-members. Additional information on this course is

available at cpnp.org/apna

Course Components Include1. A book containing 14 modules each consisting of a comprehensive outline on the topic area, expansive references, and self-assessment questions.2. Online access to expert, case-based speaker presentations on the 14 topics.3. Access to the CPNP testing center with exam submission due by December 31, 2013 (for-credit version only).4. Up to twenty contact hours (20.0) of ACPE credit upon successful completion of the required examinations for each topic area (for-credit version only).

Course RequirementsTo satisfactorily complete the CPNP Review Course in Psychiatric Pharmacy (for-credit version) and receive up to 20.0 contact hours of ACPE credit, registrants must meet the following requirements:

Abide by a confidentiality and honesty statement requiring individual completion of the Review Course.

College of Psychiatric &Neurologic Pharmacists (CPNP)8055 O Street, Ste S113Lincoln, NE 68510(402) 476-1677 phone(888) 551-7617 fax Email: info@cpnp.orgWebsite: cpnp.org

ACurriculum and uthors/Speakers

1.0 Aggression,Agitation andDelirium

Matthew Fuller, PharmD, BCPS,BCPP, FASHPClinical Pharmacy SpecialistLouis Stokes Clevelend VAMC

Sarah Melton, PharmD, BCPP, CGPDirector of ACP Addiction Outreach,Associate Professor of PharmacyPractice, Appalachian College ofPharmacy

Linda Tyler, PharmD, AdministrativeDirector of Pharmacy Services,University of Utah Hospitals and Clinics

Rene Endow-Eyer, PharmD, BCPPPsychiatric Clinical Pharmacy Specialst,VA San Diego Healthcare System

Beth Hall, PharmD, BCPP, ClinicalManager, Fulton State Hospital

Karen Rascati, PhD, Professor,The University of Texas College ofPharmacy

Jason Noel, PharmD, BCPP, AssistantProfessor, University of MarylandSchool of Pharmacy

Kelly Gable, PharmD, BCPPAssistant Professor, Southern IllinoisUniversity School of Pharmacy

Ben Chavez, PharmD, BCPPClinical Assistant Professor, RutgersState University of New Jersey

Christopher Thomas, PharmD,BCPP, BCPS, CGP, FASCP, ClinicalPharmacy Specialist in Psychiatry,Chillicothe Department of VeteransAffairs Medical Center

Ann Richards, PharmD, BCPPPharmacy Director, Texas Departmentof State Health Services

Mary Borovicka, PharmD, BCPP,BCPS, Associate Professor, Universityof Toledo

Michael Wincor, PharmD, BCPPAssociate Professor, University ofSouthern California School ofPharmacy and Medicine

1.5 AnxietyDisorders

1.5 Biostatistics andResearch Designin Psychiatry

1.5 BipolarDisorder

1.5 Depression

1.5 Economic andOutcome Studiesin Psychiatry

1.5 NeurologicDisorders

1.0 Personality andEating Disorders

1.0 PediatricPsychiatric Issues

1.5 PsychiatricIssues inthe Elderly

2.0 Regulatory Issuesin PharmacyPractice

Troy Moore, PharmD, MSPharm,BCPP, Assistant Professor,Schizophrenia and Related Disorders,The University of Texas HealthSciences Center

1.5 Schizophreniaand MovementDisorders

1.5 Sleep Disorders

1.5 SubstanceAbuse Disorders

Hours Topics Curriculum Authors & Speakers

•

•

•

Complete an online examination for each of the 14 topic areas by the deadline of December 31, 2013.Meet the minimum passing score of 60% on each of the 14 examinations. Partial credit is available with up to 20 ACPE contact hours achievable upon successfulcompletion of each examination.

Pharmacotherapy Review Course TestimonialsThe course was great as both a resource and a review! I really appreciate having the option of a quality course asa distance option! —Patti GardnerThis review course is a great refresher of psychopharmacology, especially for those healthcare professionals prescribing or administering psychiatric medications on a routine basis. The self-paced learning format with both audio and visual educational tools makes the process very convenient. I highly recommend this review course for nurses, especially APNs, as a valuable continuing education opportunity.

—Jennifer Boggs, MSN, PMHNP-BC

Aggression, Agitation and Delirium

Anxiety Disorders

Biostatistics and Research Design in Psychiatry

Bipolar Disorder

Depression

Economic and Outcome Studies in Psychiatry

Neurologic Disorders

Pediatric Psychiatric Issues

Personality and Eating Disorders

Psychiatry Issues in the Elderly

Regulatory Issues in Pharmacy

Schizophrenia and Movement Disorders

Sleep Disorders

Substance Abuse Disorders

1

2

1.5

1.5

1.5

1

1.5

1.5

1

1.5

1.5

1.5

1.5

1.5

Matthew Fuller, PharmD, BCPS, BCPP, FASHP, Clinical Pharmacy Specialist, Louis Stokes Cleveland Veterans Affairs Medical Center

Sarah Melton, PharmD, BCPP, CGP, Associate Professor of Pharmacy Practice, Appalachian College of Pharmacy

Leslie Ochs PharmD, PhD, MSPH, Assistant Professor, University of New England

Susan Leckband, PharmD, BCPP, Psychiatric Clinical Pharmacist, Veterans Affairs San Diego Healthcare System

Beth Hall, PharmD, BCPP, Clinical Pharmacist, Fulton State Hospita

Karen Rascati, PhD, Professor, The University of Texas at Austin

Jason Noel, PharmD, BCPP, Associate Professor, University of Maryland

Benjamin Chavez, PharmD, BCPP, Assistant Professor, University of Hawaii at Hilo

Kelly Gable, PharmD, BCPP, Assistant Professor, SIUE School of Pharmacy

Chris Thomas, PharmD, BCPP, BCPS, CGP, Clinical Pharmacy Specialist, Chillicothe Veterans Affairs Medical Center

Ann Richards, PharmD, BCPP, Pharmacy Director, Texas Department of State Health Services

Heidi Wehring, PharmD, BCPP, Instructor, Maryland Psychiatric Research Center

Ericka Breden, PharmD, BCPP, CGP, Clinical Pharmacy Specialist, Virginia Commonwealth University Health System

Christian Teter, PharmD, BCPP Assistant Professor, University of New England

Course ObjectivesAfter completing this course, the participant will beable to:

1. Describe the etiology, risk factors, pathophysiology, and treatment of the following: schizophrenia and other psychotic disorders, neurological disorders, psychiatric disorders in children and adolescents, anxiety disorders, sleep disorders, substance use disorders, bipolar disorders, developmental disorders, psychiatric disorders in the elderly, eating disorders, personality disorders, seizure disorders, and depression.2. Identify common signs and symptoms based on the DSM IV-TR criteria, the presentation, and clinical course of the above named psychiatric disorders.3. Resolve drug therapy problems by modifying the pharmacotherapeutic plan and developing an appropriate monitoring plan for people with the above named disorders. 4. Outline a plan to prevent or manage adverse reactions and drug-drug interactions for patients receiving pharmacologic treatment for the above named disorders. 5. Provide appropriate patient and family counseling for people with mental illness and assist patients in identifying ogranizations that provide support and advocacy.

6. Evaluate and interpret the biomedical literature to enhance the pharmacotherapy of patients withpsychiatric and neurologic conditions.

7. Describe the roles of regulatory organizations andhow they affect psychiatric and neurologic pharmacypractice and the standards of patient care.

The College of Psychiatric and NeurologicPharmacists is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 CPNP-APNA Psychiatric Pharmacotherapy Review

Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

The cost of this distance education program is $320 at member rates and $480 at non-member rates. The course is alsoavailable as a no-credit option at $150 for members andnon-members. Additional information on this course is

available at cpnp.org/apna

Course Components Include1. A book containing 14 modules each consisting of a comprehensive outline on the topic area, expansive references, and self-assessment questions.2. Online access to expert, case-based speaker presentations on the 14 topics.3. Access to the CPNP testing center with exam submission due by December 31, 2013 (for-credit version only).4. Up to twenty contact hours (20.0) of ACPE credit upon successful completion of the required examinations for each topic area (for-credit version only).

Course RequirementsTo satisfactorily complete the CPNP Review Course in Psychiatric Pharmacy (for-credit version) and receive up to 20.0 contact hours of ACPE credit, registrants must meet the following requirements:

Abide by a confidentiality and honesty statement requiring individual completion of the Review Course.

College of Psychiatric &Neurologic Pharmacists (CPNP)8055 O Street, Ste S113Lincoln, NE 68510(402) 476-1677 phone(888) 551-7617 fax Email: info@cpnp.orgWebsite: cpnp.org

ACurriculum and uthors/Speakers

1.0 Aggression,Agitation andDelirium

Matthew Fuller, PharmD, BCPS,BCPP, FASHPClinical Pharmacy SpecialistLouis Stokes Clevelend VAMC

Sarah Melton, PharmD, BCPP, CGPDirector of ACP Addiction Outreach,Associate Professor of PharmacyPractice, Appalachian College ofPharmacy

Linda Tyler, PharmD, AdministrativeDirector of Pharmacy Services,University of Utah Hospitals and Clinics

Rene Endow-Eyer, PharmD, BCPPPsychiatric Clinical Pharmacy Specialst,VA San Diego Healthcare System

Beth Hall, PharmD, BCPP, ClinicalManager, Fulton State Hospital

Karen Rascati, PhD, Professor,The University of Texas College ofPharmacy

Jason Noel, PharmD, BCPP, AssistantProfessor, University of MarylandSchool of Pharmacy

Kelly Gable, PharmD, BCPPAssistant Professor, Southern IllinoisUniversity School of Pharmacy

Ben Chavez, PharmD, BCPPClinical Assistant Professor, RutgersState University of New Jersey

Christopher Thomas, PharmD,BCPP, BCPS, CGP, FASCP, ClinicalPharmacy Specialist in Psychiatry,Chillicothe Department of VeteransAffairs Medical Center

Ann Richards, PharmD, BCPPPharmacy Director, Texas Departmentof State Health Services

Mary Borovicka, PharmD, BCPP,BCPS, Associate Professor, Universityof Toledo

Michael Wincor, PharmD, BCPPAssociate Professor, University ofSouthern California School ofPharmacy and Medicine

1.5 AnxietyDisorders

1.5 Biostatistics andResearch Designin Psychiatry

1.5 BipolarDisorder

1.5 Depression

1.5 Economic andOutcome Studiesin Psychiatry

1.5 NeurologicDisorders

1.0 Personality andEating Disorders

1.0 PediatricPsychiatric Issues

1.5 PsychiatricIssues inthe Elderly

2.0 Regulatory Issuesin PharmacyPractice

Troy Moore, PharmD, MSPharm,BCPP, Assistant Professor,Schizophrenia and Related Disorders,The University of Texas HealthSciences Center

1.5 Schizophreniaand MovementDisorders

1.5 Sleep Disorders

1.5 SubstanceAbuse Disorders

Hours Topics Curriculum Authors & Speakers

•

•

•

Complete an online examination for each of the 14 topic areas by the deadline of December 31, 2013.Meet the minimum passing score of 60% on each of the 14 examinations. Partial credit is available with up to 20 ACPE contact hours achievable upon successfulcompletion of each examination.

Pharmacotherapy Review Course TestimonialsThe course was great as both a resource and a review! I really appreciate having the option of a quality course asa distance option! —Patti GardnerThis review course is a great refresher of psychopharmacology, especially for those healthcare professionals prescribing or administering psychiatric medications on a routine basis. The self-paced learning format with both audio and visual educational tools makes the process very convenient. I highly recommend this review course for nurses, especially APNs, as a valuable continuing education opportunity.

—Jennifer Boggs, MSN, PMHNP-BC

Course ObjectivesAfter completing this course, the participant will beable to:

1. Describe the etiology, risk factors, pathophysiology, and treatment of the following: schizophrenia and other psychotic disorders, neurological disorders, psychiatric disorders in children and adolescents, anxiety disorders, sleep disorders, substance use disorders, bipolar disorders, developmental disorders, psychiatric disorders in the elderly, eating disorders, personality disorders, seizure disorders, and depression.2. Identify common signs and symptoms based on the DSM IV-TR criteria, the presentation, and clinical course of the above named psychiatric disorders.3. Resolve drug therapy problems by modifying the pharmacotherapeutic plan and developing an appropriate monitoring plan for people with the above named disorders. 4. Outline a plan to prevent or manage adverse reactions and drug-drug interactions for patients receiving pharmacologic treatment for the above named disorders. 5. Provide appropriate patient and family counseling for people with mental illness and assist patients in identifying ogranizations that provide support and advocacy.

6. Evaluate and interpret the biomedical literature to enhance the pharmacotherapy of patients withpsychiatric and neurologic conditions.

7. Describe the roles of regulatory organizations andhow they affect psychiatric and neurologic pharmacypractice and the standards of patient care.

The College of Psychiatric and NeurologicPharmacists is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 CPNP-APNA Psychiatric Pharmacotherapy Review

Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

The cost of this distance education program is $320 at member rates and $480 at non-member rates. The course is alsoavailable as a no-credit option at $150 for members andnon-members. Additional information on this course is

available at cpnp.org/apna

Course Components Include1. A book containing 14 modules each consisting of a comprehensive outline on the topic area, expansive references, and self-assessment questions.2. Online access to expert, case-based speaker presentations on the 14 topics.3. Access to the CPNP testing center with exam submission due by December 31, 2013 (for-credit version only).4. Up to twenty contact hours (20.0) of ACPE credit upon successful completion of the required examinations for each topic area (for-credit version only).

Course RequirementsTo satisfactorily complete the CPNP Review Course in Psychiatric Pharmacy (for-credit version) and receive up to 20.0 contact hours of ACPE credit, registrants must meet the following requirements:

Abide by a confidentiality and honesty statement requiring individual completion of the Review Course.

College of Psychiatric &Neurologic Pharmacists (CPNP)8055 O Street, Ste S113Lincoln, NE 68510(402) 476-1677 phone(888) 551-7617 fax Email: info@cpnp.orgWebsite: cpnp.org

ACurriculum and uthors/Speakers

1.0 Aggression,Agitation andDelirium

Matthew Fuller, PharmD, BCPS,BCPP, FASHPClinical Pharmacy SpecialistLouis Stokes Clevelend VAMC

Sarah Melton, PharmD, BCPP, CGPDirector of ACP Addiction Outreach,Associate Professor of PharmacyPractice, Appalachian College ofPharmacy

Linda Tyler, PharmD, AdministrativeDirector of Pharmacy Services,University of Utah Hospitals and Clinics

Rene Endow-Eyer, PharmD, BCPPPsychiatric Clinical Pharmacy Specialst,VA San Diego Healthcare System

Beth Hall, PharmD, BCPP, ClinicalManager, Fulton State Hospital

Karen Rascati, PhD, Professor,The University of Texas College ofPharmacy

Jason Noel, PharmD, BCPP, AssistantProfessor, University of MarylandSchool of Pharmacy

Kelly Gable, PharmD, BCPPAssistant Professor, Southern IllinoisUniversity School of Pharmacy

Ben Chavez, PharmD, BCPPClinical Assistant Professor, RutgersState University of New Jersey

Christopher Thomas, PharmD,BCPP, BCPS, CGP, FASCP, ClinicalPharmacy Specialist in Psychiatry,Chillicothe Department of VeteransAffairs Medical Center

Ann Richards, PharmD, BCPPPharmacy Director, Texas Departmentof State Health Services

Mary Borovicka, PharmD, BCPP,BCPS, Associate Professor, Universityof Toledo

Michael Wincor, PharmD, BCPPAssociate Professor, University ofSouthern California School ofPharmacy and Medicine

1.5 AnxietyDisorders

1.5 Biostatistics andResearch Designin Psychiatry

1.5 BipolarDisorder

1.5 Depression

1.5 Economic andOutcome Studiesin Psychiatry

1.5 NeurologicDisorders

1.0 Personality andEating Disorders

1.0 PediatricPsychiatric Issues

1.5 PsychiatricIssues inthe Elderly

2.0 Regulatory Issuesin PharmacyPractice

Troy Moore, PharmD, MSPharm,BCPP, Assistant Professor,Schizophrenia and Related Disorders,The University of Texas HealthSciences Center

1.5 Schizophreniaand MovementDisorders

1.5 Sleep Disorders

1.5 SubstanceAbuse Disorders

Hours Topics Curriculum Authors & Speakers

•

•

•

Complete an online examination for each of the 14 topic areas by the deadline of December 31, 2013.Meet the minimum passing score of 60% on each of the 14 examinations. Partial credit is available with up to 20 ACPE contact hours achievable upon successfulcompletion of each examination.

Pharmacotherapy Review Course TestimonialsThe course was great as both a resource and a review! I really appreciate having the option of a quality course asa distance option! —Patti GardnerThis review course is a great refresher of psychopharmacology, especially for those healthcare professionals prescribing or administering psychiatric medications on a routine basis. The self-paced learning format with both audio and visual educational tools makes the process very convenient. I highly recommend this review course for nurses, especially APNs, as a valuable continuing education opportunity.

—Jennifer Boggs, MSN, PMHNP-BC

Aggression, Agitation and Delirium

Anxiety Disorders

Biostatistics and Research Design in Psychiatry

Bipolar Disorder

Depression

Economic and Outcome Studies in Psychiatry

Neurologic Disorders

Pediatric Psychiatric Issues

Personality and Eating Disorders

Psychiatry Issues in the Elderly

Regulatory Issues in Pharmacy

Schizophrenia and Movement Disorders

Sleep Disorders

Substance Abuse Disorders

1

2

1.5

1.5

1.5

1

1.5

1.5

1

1.5

1.5

1.5

1.5

1.5

Matthew Fuller, PharmD, BCPS, BCPP, FASHP, Clinical Pharmacy Specialist, Louis Stokes Cleveland Veterans Affairs Medical Center

Sarah Melton, PharmD, BCPP, CGP, Associate Professor of Pharmacy Practice, Appalachian College of Pharmacy

Leslie Ochs PharmD, PhD, MSPH, Assistant Professor, University of New England

Susan Leckband, PharmD, BCPP, Psychiatric Clinical Pharmacist, Veterans Affairs San Diego Healthcare System

Beth Hall, PharmD, BCPP, Clinical Pharmacist, Fulton State Hospita

Karen Rascati, PhD, Professor, The University of Texas at Austin

Jason Noel, PharmD, BCPP, Associate Professor, University of Maryland

Benjamin Chavez, PharmD, BCPP, Assistant Professor, University of Hawaii at Hilo

Kelly Gable, PharmD, BCPP, Assistant Professor, SIUE School of Pharmacy

Chris Thomas, PharmD, BCPP, BCPS, CGP, Clinical Pharmacy Specialist, Chillicothe Veterans Affairs Medical Center

Ann Richards, PharmD, BCPP, Pharmacy Director, Texas Department of State Health Services

Heidi Wehring, PharmD, BCPP, Instructor, Maryland Psychiatric Research Center

Ericka Breden, PharmD, BCPP, CGP, Clinical Pharmacy Specialist, Virginia Commonwealth University Health System

Christian Teter, PharmD, BCPP Assistant Professor, University of New England

Course ObjectivesAfter completing this course, the participant will beable to:

1. Describe the etiology, risk factors, pathophysiology, and treatment of the following: schizophrenia and other psychotic disorders, neurological disorders, psychiatric disorders in children and adolescents, anxiety disorders, sleep disorders, substance use disorders, bipolar disorders, developmental disorders, psychiatric disorders in the elderly, eating disorders, personality disorders, seizure disorders, and depression.2. Identify common signs and symptoms based on the DSM IV-TR criteria, the presentation, and clinical course of the above named psychiatric disorders.3. Resolve drug therapy problems by modifying the pharmacotherapeutic plan and developing an appropriate monitoring plan for people with the above named disorders. 4. Outline a plan to prevent or manage adverse reactions and drug-drug interactions for patients receiving pharmacologic treatment for the above named disorders. 5. Provide appropriate patient and family counseling for people with mental illness and assist patients in identifying ogranizations that provide support and advocacy.

6. Evaluate and interpret the biomedical literature to enhance the pharmacotherapy of patients withpsychiatric and neurologic conditions.

7. Describe the roles of regulatory organizations andhow they affect psychiatric and neurologic pharmacypractice and the standards of patient care.

The College of Psychiatric and NeurologicPharmacists is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 CPNP-APNA Psychiatric Pharmacotherapy Review

Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

The cost of this distance education program is $320 at member rates and $480 at non-member rates. The course is alsoavailable as a no-credit option at $150 for members andnon-members. Additional information on this course is

available at cpnp.org/apna

Course Components Include1. A book containing 14 modules each consisting of a comprehensive outline on the topic area, expansive references, and self-assessment questions.2. Online access to expert, case-based speaker presentations on the 14 topics.3. Access to the CPNP testing center with exam submission due by December 31, 2013 (for-credit version only).4. Up to twenty contact hours (20.0) of ACPE credit upon successful completion of the required examinations for each topic area (for-credit version only).

Course RequirementsTo satisfactorily complete the CPNP Review Course in Psychiatric Pharmacy (for-credit version) and receive up to 20.0 contact hours of ACPE credit, registrants must meet the following requirements:

Abide by a confidentiality and honesty statement requiring individual completion of the Review Course.

College of Psychiatric &Neurologic Pharmacists (CPNP)8055 O Street, Ste S113Lincoln, NE 68510(402) 476-1677 phone(888) 551-7617 fax Email: info@cpnp.orgWebsite: cpnp.org

ACurriculum and uthors/Speakers

1.0 Aggression,Agitation andDelirium

Matthew Fuller, PharmD, BCPS,BCPP, FASHPClinical Pharmacy SpecialistLouis Stokes Clevelend VAMC

Sarah Melton, PharmD, BCPP, CGPDirector of ACP Addiction Outreach,Associate Professor of PharmacyPractice, Appalachian College ofPharmacy

Linda Tyler, PharmD, AdministrativeDirector of Pharmacy Services,University of Utah Hospitals and Clinics

Rene Endow-Eyer, PharmD, BCPPPsychiatric Clinical Pharmacy Specialst,VA San Diego Healthcare System

Beth Hall, PharmD, BCPP, ClinicalManager, Fulton State Hospital

Karen Rascati, PhD, Professor,The University of Texas College ofPharmacy

Jason Noel, PharmD, BCPP, AssistantProfessor, University of MarylandSchool of Pharmacy

Kelly Gable, PharmD, BCPPAssistant Professor, Southern IllinoisUniversity School of Pharmacy

Ben Chavez, PharmD, BCPPClinical Assistant Professor, RutgersState University of New Jersey

Christopher Thomas, PharmD,BCPP, BCPS, CGP, FASCP, ClinicalPharmacy Specialist in Psychiatry,Chillicothe Department of VeteransAffairs Medical Center

Ann Richards, PharmD, BCPPPharmacy Director, Texas Departmentof State Health Services

Mary Borovicka, PharmD, BCPP,BCPS, Associate Professor, Universityof Toledo

Michael Wincor, PharmD, BCPPAssociate Professor, University ofSouthern California School ofPharmacy and Medicine

1.5 AnxietyDisorders

1.5 Biostatistics andResearch Designin Psychiatry

1.5 BipolarDisorder

1.5 Depression

1.5 Economic andOutcome Studiesin Psychiatry

1.5 NeurologicDisorders

1.0 Personality andEating Disorders

1.0 PediatricPsychiatric Issues

1.5 PsychiatricIssues inthe Elderly

2.0 Regulatory Issuesin PharmacyPractice

Troy Moore, PharmD, MSPharm,BCPP, Assistant Professor,Schizophrenia and Related Disorders,The University of Texas HealthSciences Center

1.5 Schizophreniaand MovementDisorders

1.5 Sleep Disorders

1.5 SubstanceAbuse Disorders

Hours Topics Curriculum Authors & Speakers

•

•

•

Complete an online examination for each of the 14 topic areas by the deadline of December 31, 2013.Meet the minimum passing score of 60% on each of the 14 examinations. Partial credit is available with up to 20 ACPE contact hours achievable upon successfulcompletion of each examination.

Pharmacotherapy Review Course TestimonialsThe course was great as both a resource and a review! I really appreciate having the option of a quality course asa distance option! —Patti GardnerThis review course is a great refresher of psychopharmacology, especially for those healthcare professionals prescribing or administering psychiatric medications on a routine basis. The self-paced learning format with both audio and visual educational tools makes the process very convenient. I highly recommend this review course for nurses, especially APNs, as a valuable continuing education opportunity.

—Jennifer Boggs, MSN, PMHNP-BC

Course ObjectivesAfter completing this course, the participant will beable to:

1. Describe the etiology, risk factors, pathophysiology, and treatment of the following: schizophrenia and other psychotic disorders, neurological disorders, psychiatric disorders in children and adolescents, anxiety disorders, sleep disorders, substance use disorders, bipolar disorders, developmental disorders, psychiatric disorders in the elderly, eating disorders, personality disorders, seizure disorders, and depression.2. Identify common signs and symptoms based on the DSM IV-TR criteria, the presentation, and clinical course of the above named psychiatric disorders.3. Resolve drug therapy problems by modifying the pharmacotherapeutic plan and developing an appropriate monitoring plan for people with the above named disorders. 4. Outline a plan to prevent or manage adverse reactions and drug-drug interactions for patients receiving pharmacologic treatment for the above named disorders. 5. Provide appropriate patient and family counseling for people with mental illness and assist patients in identifying ogranizations that provide support and advocacy.

6. Evaluate and interpret the biomedical literature to enhance the pharmacotherapy of patients withpsychiatric and neurologic conditions.

7. Describe the roles of regulatory organizations andhow they affect psychiatric and neurologic pharmacypractice and the standards of patient care.

The College of Psychiatric and NeurologicPharmacists is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 CPNP-APNA Psychiatric Pharmacotherapy Review

Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

The cost of this distance education program is $320 at member rates and $480 at non-member rates. The course is alsoavailable as a no-credit option at $150 for members andnon-members. Additional information on this course is

available at cpnp.org/apna

Course Components Include1. A book containing 14 modules each consisting of a comprehensive outline on the topic area, expansive references, and self-assessment questions.2. Online access to expert, case-based speaker presentations on the 14 topics.3. Access to the CPNP testing center with exam submission due by December 31, 2013 (for-credit version only).4. Up to twenty contact hours (20.0) of ACPE credit upon successful completion of the required examinations for each topic area (for-credit version only).

Course RequirementsTo satisfactorily complete the CPNP Review Course in Psychiatric Pharmacy (for-credit version) and receive up to 20.0 contact hours of ACPE credit, registrants must meet the following requirements:

Abide by a confidentiality and honesty statement requiring individual completion of the Review Course.

College of Psychiatric &Neurologic Pharmacists (CPNP)8055 O Street, Ste S113Lincoln, NE 68510(402) 476-1677 phone(888) 551-7617 fax Email: info@cpnp.orgWebsite: cpnp.org

ACurriculum and uthors/Speakers

1.0 Aggression,Agitation andDelirium

Matthew Fuller, PharmD, BCPS,BCPP, FASHPClinical Pharmacy SpecialistLouis Stokes Clevelend VAMC

Sarah Melton, PharmD, BCPP, CGPDirector of ACP Addiction Outreach,Associate Professor of PharmacyPractice, Appalachian College ofPharmacy

Linda Tyler, PharmD, AdministrativeDirector of Pharmacy Services,University of Utah Hospitals and Clinics

Rene Endow-Eyer, PharmD, BCPPPsychiatric Clinical Pharmacy Specialst,VA San Diego Healthcare System

Beth Hall, PharmD, BCPP, ClinicalManager, Fulton State Hospital

Karen Rascati, PhD, Professor,The University of Texas College ofPharmacy

Jason Noel, PharmD, BCPP, AssistantProfessor, University of MarylandSchool of Pharmacy

Kelly Gable, PharmD, BCPPAssistant Professor, Southern IllinoisUniversity School of Pharmacy

Ben Chavez, PharmD, BCPPClinical Assistant Professor, RutgersState University of New Jersey

Christopher Thomas, PharmD,BCPP, BCPS, CGP, FASCP, ClinicalPharmacy Specialist in Psychiatry,Chillicothe Department of VeteransAffairs Medical Center

Ann Richards, PharmD, BCPPPharmacy Director, Texas Departmentof State Health Services

Mary Borovicka, PharmD, BCPP,BCPS, Associate Professor, Universityof Toledo

Michael Wincor, PharmD, BCPPAssociate Professor, University ofSouthern California School ofPharmacy and Medicine

1.5 AnxietyDisorders

1.5 Biostatistics andResearch Designin Psychiatry

1.5 BipolarDisorder

1.5 Depression

1.5 Economic andOutcome Studiesin Psychiatry

1.5 NeurologicDisorders

1.0 Personality andEating Disorders

1.0 PediatricPsychiatric Issues

1.5 PsychiatricIssues inthe Elderly

2.0 Regulatory Issuesin PharmacyPractice

Troy Moore, PharmD, MSPharm,BCPP, Assistant Professor,Schizophrenia and Related Disorders,The University of Texas HealthSciences Center

1.5 Schizophreniaand MovementDisorders

1.5 Sleep Disorders

1.5 SubstanceAbuse Disorders

Hours Topics Curriculum Authors & Speakers

•

•

•

Complete an online examination for each of the 14 topic areas by the deadline of December 31, 2013.Meet the minimum passing score of 60% on each of the 14 examinations. Partial credit is available with up to 20 ACPE contact hours achievable upon successfulcompletion of each examination.

Pharmacotherapy Review Course TestimonialsThe course was great as both a resource and a review! I really appreciate having the option of a quality course asa distance option! —Patti GardnerThis review course is a great refresher of psychopharmacology, especially for those healthcare professionals prescribing or administering psychiatric medications on a routine basis. The self-paced learning format with both audio and visual educational tools makes the process very convenient. I highly recommend this review course for nurses, especially APNs, as a valuable continuing education opportunity.

—Jennifer Boggs, MSN, PMHNP-BC

Aggression, Agitation and Delirium

Anxiety Disorders

Biostatistics and Research Design in Psychiatry

Bipolar Disorder

Depression

Economic and Outcome Studies in Psychiatry

Neurologic Disorders

Pediatric Psychiatric Issues

Personality and Eating Disorders

Psychiatry Issues in the Elderly

Regulatory Issues in Pharmacy

Schizophrenia and Movement Disorders

Sleep Disorders

Substance Abuse Disorders

1

2

1.5

1.5

1.5

1

1.5

1.5

1

1.5

1.5

1.5

1.5

1.5

Matthew Fuller, PharmD, BCPS, BCPP, FASHP, Clinical Pharmacy Specialist, Louis Stokes Cleveland Veterans Affairs Medical Center

Sarah Melton, PharmD, BCPP, CGP, Associate Professor of Pharmacy Practice, Appalachian College of Pharmacy

Leslie Ochs PharmD, PhD, MSPH, Assistant Professor, University of New England

Susan Leckband, PharmD, BCPP, Psychiatric Clinical Pharmacist, Veterans Affairs San Diego Healthcare System

Beth Hall, PharmD, BCPP, Clinical Pharmacist, Fulton State Hospita

Karen Rascati, PhD, Professor, The University of Texas at Austin

Jason Noel, PharmD, BCPP, Associate Professor, University of Maryland

Benjamin Chavez, PharmD, BCPP, Assistant Professor, University of Hawaii at Hilo

Kelly Gable, PharmD, BCPP, Assistant Professor, SIUE School of Pharmacy

Chris Thomas, PharmD, BCPP, BCPS, CGP, Clinical Pharmacy Specialist, Chillicothe Veterans Affairs Medical Center

Ann Richards, PharmD, BCPP, Pharmacy Director, Texas Department of State Health Services

Heidi Wehring, PharmD, BCPP, Instructor, Maryland Psychiatric Research Center

Ericka Breden, PharmD, BCPP, CGP, Clinical Pharmacy Specialist, Virginia Commonwealth University Health System

Christian Teter, PharmD, BCPP Assistant Professor, University of New England